{"rows":[{"id":2524,"title":"Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.","authors":"Tófoli LF, de Araujo DB","journal":"International review of neurobiology","publication_date":"2016-01-01","publication_year":2016,"doi":"10.1016/bs.irn.2016.06.005","pubmed_id":"27503452","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/27503452/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Brain Imaging,Aging,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:27503452","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/27503452/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:27503452","source_url":"https://pubmed.ncbi.nlm.nih.gov/27503452/","doi":"10.1016/bs.irn.2016.06.005","pmid":"27503452","publication_date":"2016-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1266,"title":"Ayahuasca for the treatment of alcohol use disorder.","authors":"Marinho EAV, Serra YA, Oliveira-Lima AJ, Marcourakis T, Berro LF","journal":"International review of neurobiology","publication_date":"2024-01-01","publication_year":2024,"doi":"10.1016/bs.irn.2024.07.007","pubmed_id":"39523057","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39523057/","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:11","bibtex":null,"source_record_id":"PMID:39523057","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39523057/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39523057","source_url":"https://pubmed.ncbi.nlm.nih.gov/39523057/","doi":"10.1016/bs.irn.2024.07.007","pmid":"39523057","publication_date":"2024-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":889,"title":"Human neuroimaging: fMRI.","authors":"Wall MB, Carhart-Harris RL","journal":"International review of neurobiology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/bs.irn.2025.04.013","pubmed_id":"40541308","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40541308/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Pharmacology,Aging,Emotional Processing,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:40541308","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40541308/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40541308","source_url":"https://pubmed.ncbi.nlm.nih.gov/40541308/","doi":"10.1016/bs.irn.2025.04.013","pmid":"40541308","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":888,"title":"Effects of psychedelics on human oscillatory brain activity.","authors":"Godfrey K, Luan LX, Timmermann C","journal":"International review of neurobiology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/bs.irn.2025.04.012","pubmed_id":"40541309","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40541309/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Mechanism of Action,Biomarkers,Aging,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:40541309","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40541309/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40541309","source_url":"https://pubmed.ncbi.nlm.nih.gov/40541309/","doi":"10.1016/bs.irn.2025.04.012","pmid":"40541309","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":887,"title":"Molecular brain imaging of psychedelic action.","authors":"Cumming P, Egger K, Knudsen GM","journal":"International review of neurobiology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/bs.irn.2025.02.005","pubmed_id":"40541310","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40541310/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Review Article,Drug Interactions","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:40541310","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40541310/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40541310","source_url":"https://pubmed.ncbi.nlm.nih.gov/40541310/","doi":"10.1016/bs.irn.2025.02.005","pmid":"40541310","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":886,"title":"Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?","authors":"Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC","journal":"International review of neurobiology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/bs.irn.2025.03.002","pubmed_id":"40541311","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40541311/","substance_tags":"psilocybin","topic_tags":"Depression,OCD,Chronic Pain,Pharmacology,Microdosing,Clinical Trial,Review Article,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:40541311","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40541311/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40541311","source_url":"https://pubmed.ncbi.nlm.nih.gov/40541311/","doi":"10.1016/bs.irn.2025.03.002","pmid":"40541311","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":885,"title":"Serotonergic psychedelics for depression: A comprehensive overview.","authors":"Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D","journal":"International review of neurobiology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/bs.irn.2025.04.009","pubmed_id":"40541312","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40541312/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:40541312","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40541312/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40541312","source_url":"https://pubmed.ncbi.nlm.nih.gov/40541312/","doi":"10.1016/bs.irn.2025.04.009","pmid":"40541312","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":884,"title":"Psychedelics and substance use disorder treatment.","authors":"DuPont CM, Johnson MW","journal":"International review of neurobiology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/bs.irn.2025.03.005","pubmed_id":"40541314","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40541314/","substance_tags":"psilocybin","topic_tags":"Addiction,Emotional Processing,Clinical Trial,Observational Study,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:40541314","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40541314/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40541314","source_url":"https://pubmed.ncbi.nlm.nih.gov/40541314/","doi":"10.1016/bs.irn.2025.03.005","pmid":"40541314","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":883,"title":"Post-traumatic stress disorder in psychedelic research.","authors":"Bostoen T, Tap S, Breeksema J, Schoevers R","journal":"International review of neurobiology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/bs.irn.2025.02.004","pubmed_id":"40541315","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40541315/","substance_tags":"psilocybin","topic_tags":"PTSD,Mechanism of Action,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:40541315","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40541315/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40541315","source_url":"https://pubmed.ncbi.nlm.nih.gov/40541315/","doi":"10.1016/bs.irn.2025.02.004","pmid":"40541315","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":882,"title":"Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.","authors":"Tap S, Bostoen T, Breeksema J, Schoevers R","journal":"International review of neurobiology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/bs.irn.2025.03.001","pubmed_id":"40541316","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40541316/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Wellbeing,Emotional Processing,Spirituality","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:40541316","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40541316/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40541316","source_url":"https://pubmed.ncbi.nlm.nih.gov/40541316/","doi":"10.1016/bs.irn.2025.03.001","pmid":"40541316","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":881,"title":"Clinical pharmacology.","authors":"Vogt SB, Liechti ME","journal":"International review of neurobiology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/bs.irn.2025.02.003","pubmed_id":"40541320","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40541320/","substance_tags":"psilocybin","topic_tags":"Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Drug Interactions","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:40541320","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40541320/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40541320","source_url":"https://pubmed.ncbi.nlm.nih.gov/40541320/","doi":"10.1016/bs.irn.2025.02.003","pmid":"40541320","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":11,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"International review of neurobiology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}